首页> 外文OA文献 >Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence.
【2h】

Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence.

机译:在不良结果途径中提高科学信心:量身定制的Bradford-Hill考虑因素在评估证据权重中的应用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Systematic consideration of scientific support is a critical element in developing and, ultimately, using adverse outcome pathways (AOPs) for various regulatory applications. Though weight of evidence (WoE) analysis has been proposed as a basis for assessment of the maturity and level of confidence in an AOP, methodologies and tools are still being formalized. The Organization for Economic Co-operation and Development (OECD) Users' Handbook Supplement to the Guidance Document for Developing and Assessing AOPs (OECD 2014a; hereafter referred to as the OECD AOP Handbook) provides tailored Bradford-Hill (BH) considerations for systematic assessment of confidence in a given AOP. These considerations include (1) biological plausibility and (2) empirical support (dose-response, temporality, and incidence) for Key Event Relationships (KERs), and (3) essentiality of key events (KEs). Here, we test the application of these tailored BH considerations and the guidance outlined in the OECD AOP Handbook using a number of case examples to increase experience in more transparently documenting rationales for assigned levels of confidence to KEs and KERs, and to promote consistency in evaluation within and across AOPs. The major lessons learned from experience are documented, and taken together with the case examples, should contribute to better common understanding of the nature and form of documentation required to increase confidence in the application of AOPs for specific uses. Based on the tailored BH considerations and defining questions, a prototype quantitative model for assessing the WoE of an AOP using tools of multi-criteria decision analysis (MCDA) is described. The applicability of the approach is also demonstrated using the case example aromatase inhibition leading to reproductive dysfunction in fish. Following the acquisition of additional experience in the development and assessment of AOPs, further refinement of parameterization of the model through expert elicitation is recommended. Overall, the application of quantitative WoE approaches hold promise to enhance the rigor, transparency and reproducibility for AOP WoE determinations and may play an important role in delineating areas where research would have the greatest impact on improving the overall confidence in the AOP.
机译:系统地考虑科学支持是开发不利的结果途径(AOP)并最终用于各种监管应用的关键因素。尽管已经提出了证据权重(WoE)分析作为评估AOP的成熟度和置信度的基础,但方法和工具仍在形式化。经济合作与发展组织(OECD)用户手册,用于制定和评估AOP的指导文件补编(OECD 2014a;以下简称为OECD AOP手册)提供了量身定制的Bradford-Hill(BH)考虑因素,用于系统评估给定AOP的信心。这些考虑因素包括(1)关键事件关系(KERs)的生物学合理性和(2)经验支持(剂量反应,时间性和发生率),以及(3)关键事件(KEs)的必要性。在这里,我们使用许多案例来测试这些量身定制的BH注意事项和《 OECD AOP手册》中概述的指南的应用,以增加在更透明地记录为KE和KER分配的置信度的理由方面的经验,并促进评估的一致性在AOP之内和之间。将从经验中吸取的主要经验教训记录在案,并与案例结合在一起,应有助于更好地共识所需的文件的性质和形式,以增加对将AOP用于特定用途的信心。基于量身定制的BH考虑因素和定义的问题,描述了使用多准则决策分析(MCDA)工具评估AOP的WoE的定量模型原型。还通过案例示例芳香化酶抑制导致鱼的生殖功能障碍,证明了该方法的适用性。在获得了开发和评估AOP的额外经验后,建议通过专家指导进一步完善模型的参数化。总体而言,定量WoE方法的应用有望提高AOP WoE测定的严格性,透明度和可重复性,并且在确定研究对提高AOP总体信心的影响最大的领域中可能发挥重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号